Biotech





Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

Agenus Inc. (AGEN) Buy Target $2.80 – Sell Target $3.72

Trade Setup Buy Target $2.80 Sell Target 1 $3.34 Trailing Stop 20% Sell Target 2 $3.72 Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body’s immune system to fight cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized […]

Read More
Biotech
One Hot Stock
TradersPro Alerts

Applied Genetic Technologies Corporation (AGTC) Buy Target $4.26 – Sell Target $6.90

Trade Setup Buy Target $4.26 Sell Target 1 $5.50 Trailing Stop 20% Sell Target 2 $6.90 Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company’s lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in […]

Read More
Biotech
HeathCare
Stock Picks
Technical Analysis

One Technician Says The Breakout In Biotechs Is Just Getting Started – Here Are 3 To Buy Right Now

Biotechs are headed for a big rally, and analysts say these 3 stocks in the sector could see double-digit upside ahead.

Read More
Biotech
Daily Perspective
Pharmaceuticals

Here’s How Massive AbbVie Will Become After Buying Allergan

One of the year’s biggest merger announcements sent shockwaves through the U.S. pharmaceutical sector on Tuesday when Humira drugmaker AbbVie Inc. (ABBV) struck a deal to acquire Botox producer Allergan Plc. (AGN). Investors reacted strongly to the news, making ABBV and AGN the market’s single biggest loser and winner, respectively.  After the deal closes, AbbVie […]

Read More
Biotech
One Hot Stock
TradersPro Alerts

Generex Biotechnology Corporation (GNBT) Buy Target 1.40 – Sell Target 2 $2.85

Generex Biotechnology Corporation, through its subsidiaries, primarily engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an insulin formulation administered as a fine spray into the oral cavity. The company is also developing AE37, a […]

Read More
Biopharmaceuticals
Biotech
Fibonacci Retracement
Fundamental Analysis
InvestivDaily
Technical Analysis
Value Investing

Is GILD a bargain – or a big risk?

It seems that the only news anybody really cares about right now is the trade war. China announced yesterday that it would impose $60 billion of retaliatory tariffs against the U.S. after the Trump administration increased already imposed duties from 10% to 25% at the end of last week. That has propelled the market to […]

Read More
Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

Affimed N.V. (AFMD) Buy Target $3.56 – Sell Target $5.68

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Its lead product candidate is AFM13, a natural killer cell (NK-cell) TandAb, which is in Phase 2a clinical study of relapsed CD30-positive lymphoma and Phase 1b clinical study of anti-PD-1 antibody Keytruda (pembrolizumab) in patients […]

Read More
Biopharmaceuticals
Biotech
Stock Picks

These 2 Biotechs Could Be The Next Big Takeover Targets

Both have catalysts coming up that could make them prime candidates for a buyout.

Read More